Chester County News and Community Website
WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has received Breakthrough Therapy Designation from the U.S. Food and Drug …
ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook Read More WILMINGTON, DE — AstraZeneca PLC (NASDAQ: AZN) and Japan’s Daiichi Sankyo said the U.S. Food and Drug Administration has approved ENHERTU in combination with pertuzumab as a first-line treatment for …
FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer Read More
ANNAPOLIS, MD & PHILADELPHIA, PA — Two national breast cancer nonprofits unveiled new research showing significant gains in health outcomes and quality of life for Black women with breast cancer, …
New Data Shows Care Model Dramatically Improves Black Breast Cancer Outcomes Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program has announced new funding aimed at improving treatment and care delivery for people living with metastatic, or …
New Research Funding Targets Gaps in Care for Stage Four Breast Cancer Read More
MOUNTVILLE, PA — Field of Screams turned adrenaline and community spirit into tangible impact this fall, raising $8,400 for the Pennsylvania Breast Cancer Coalition during its 13th annual Zombie Fun …
Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care Read More WILMINGTON, DE — In a major advance for breast cancer treatment, AstraZeneca and Daiichi Sankyo announced that their drug DATROWAY (datopotamab deruxtecan-dlnk) extended the lives of patients with metastatic triple-negative …
Breakthrough Drug Shows Unprecedented Survival Gains in Aggressive Breast Cancer Read More
WILKES-BARRE, PA — The Shapiro Administration on Tuesday spotlighted a new artificial intelligence program being used at Geisinger Wyoming Valley Medical Center to identify women at high risk for breast …
Pennsylvania Expands Use of AI in Breast Cancer Detection, Aims to Boost Early Diagnosis and Save Lives Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their antibody-drug conjugate ENHERTU® (fam-trastuzumab deruxtecan-nxki), when used before surgery and followed by standard therapy, achieved a pathologic complete response in …
ENHERTU Combination Shows Promising Results in Early Breast Cancer Trial Read More ANNAPOLIS, MD & PHILADELPHIA, PA — Unite for HER and TOUCH, The Black Breast Cancer Alliance (TOUCHBBCA), have announced the 2025 Care for HER program, an initiative aimed at reducing …
Unite for HER and TOUCHBBCA Expand Care for Black Breast Cancer Patients With 2025 Program Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) last week added breast cancer treatment and genetic/familial high-risk assessment to its NCCN Guidelines Navigator™ platform, broadening access to digitized, …
NCCN Expands Digital Navigator With New Breast Cancer and Genetic Risk Resources Read More